BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28600398)

  • 1. Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.
    Rees JR; Morris CB; Peacock JL; Ueland PM; Barry EL; McKeown-Eyssen GE; Figueiredo JC; Snover DC; Baron JA
    Cancer Prev Res (Phila); 2017 Aug; 10(8):451-458. PubMed ID: 28600398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
    Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
    J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
    Wu K; Platz EA; Willett WC; Fuchs CS; Selhub J; Rosner BA; Hunter DJ; Giovannucci E
    Am J Clin Nutr; 2009 Dec; 90(6):1623-31. PubMed ID: 19864409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
    Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid and prevention of colorectal adenomas.
    Chae YK; Yun JH
    JAMA; 2007 Sep; 298(12):1397; author reply 1397. PubMed ID: 17895454
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.
    Figueiredo JC; Mott LA; Giovannucci E; Wu K; Cole B; Grainge MJ; Logan RF; Baron JA
    Int J Cancer; 2011 Jul; 129(1):192-203. PubMed ID: 21170989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmetabolized Folic Acid in Prediagnostic Plasma and the Risk of Colorectal Cancer.
    Cho E; Zhang X; Townsend MK; Selhub J; Paul L; Rosner B; Fuchs CS; Willett WC; Giovannucci EL
    J Natl Cancer Inst; 2015 Dec; 107(12):djv260. PubMed ID: 26376686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
    Figueiredo JC; Levine AJ; Grau MV; Barry EL; Ueland PM; Ahnen DJ; Byers T; Bresalier RS; Summers RW; Bond J; McKeown-Eyssen GE; Sandler RS; Haile RW; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2625-31. PubMed ID: 18843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
    Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
    Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Zhang D; Ahnen DJ; Bresalier RS; Haile RW; McKeown-Eyssen G; Snover DC; Cole BF; Baron JA
    Am J Clin Nutr; 2019 Oct; 110(4):903-911. PubMed ID: 31401653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
    J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
    Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate and cancer--timing is everything.
    Ulrich CM; Potter JD
    JAMA; 2007 Jun; 297(21):2408-9. PubMed ID: 17551134
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemopreventive agents in colorectal cancer].
    Benamouzig R; Chaussade S
    Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.